Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAltitude Group Regulatory News (ALT)

Share Price Information for Altitude Group (ALT)

Share Price is delayed by 15 minutes
Get Live Data
20.50    0.50 (2.50%)
Bid:
20.00
Ask:
21.00
Spread: 1.00 (5.00%)
Market Cap: £14.99m
ALT Live PriceLast checked at - London Stock Exchange

Intraday Altitude Group Share Chart

Full Year Trading Update

23 Jul 2024 07:00

RNS Number : 3784X
Altitude Group PLC
23 July 2024
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Group's obligations under Article 17 of MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Altitude Group plc

("Altitude" or the "Group")

FULL YEAR TRADING UPDATE

Altitude delivers record breaking results and exceeds market expectations on adjusted operating profit

 

Altitude Group Plc (AIM: ALT), the leading end-to-end solutions provider for branded merchandise beats market expectations on adjusted operating profit and achieves record breaking results for the year ended 31 March 2024 ("FY24"), showcasing accelerated scale, growth and momentum.

 

Demonstrating strength and scale, the Board is pleased to report that revenues are expected to be up 33%, at constant currency, to £24.0 million (FY23: £18.8 million) with a record Group adjusted operating profit* of £2.4 million (FY23: £2.0 million) up by 31% at constant currency and ahead of market expectations**. The Group has doubled revenues since FY22 and increased adjusted operating profit* by over 225% over the same two-year period. The Group's investment in its Merchanting divisions, including both ACS and its collegiate market disrupting University Gear Shop solution ("UGS"), have each contributed significant growth to the Group.

 

The Group's Affiliate programme, ACS, increased its annualised expected revenues for FY24 by 32% to $18.0 million (FY23: $13.6 million). This has been from a mixture of new recruitment and organic growth.

 

Current Trading

 

The current financial year ("FY25") has just completed its first full quarter of trading and the Group continues to perform well across both its Services division and its rapidly scaling Merchanting division. ACS has had a strong start to FY25, adding an additional $2 million in recruitment to reach $20 million annualised expected revenues.

 

The Group continues to expand and disrupt the collegiate market. The team have signed additional new contracts and have further campus programmes in the pipeline for this tender season which is now anticipated to extend beyond the summer months. Importantly, UGS has developed further strategic partnerships with course material providers opening further opportunities for growth. UGS has 19 campus programmes at 22 locations, with a current total lifetime contract value of c.$45 million equating to $9 million (FY23: 5 active contracts of $1 million) annualised average expected revenues.

 

With high levels of visibility and a strong start to FY25 the Board remains confident in the growth potential for Altitude for FY25 and beyond.

 

Notice of Results

The Group expects to announce its FY24 audited results on 30 July 2024.

 

Nikki Stella, CEO of Altitude, said: "This has been another year of stellar growth within the business. Altitude has delivered 6 consecutive years of growth demonstrating the strength of its people and ability to execute. We remain very confident about the future and look forward to another year of significant progress."

* Operating profit before share-based payment charges, amortisation of intangible assets, depreciation of tangible assets and exceptional charges

** External market consensus for the year ended 31 March 2024 is currently revenue of £26.1 million and adjusted EBITDA of £2.2 million.

 For enquiries, please contact:

Altitude Group plc

Nichole Stella, Chief Executive Officer

Graham Feltham, Chief Financial Officer

 

Via Zeus

Zeus (Nominated Adviser & Broker)

Dan Bate / James Edis (Investment Banking)

Alice Lane (Corporate Broking)

Tel: 0203 829 5000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQKBBPBBKBFOB
Date   Source Headline
8th Jun 20267:00 amRNSDirector/PDMR Shareholding
1st Jun 20268:31 amRNSExercise & Grant of Options and TVR
17th Apr 20267:00 amRNSBoard Role Change
14th Apr 20263:25 pmRNSDirector/PDMR Dealing
9th Apr 202612:00 pmRNSDirector/PDMR Dealing
31st Mar 20267:00 amRNSTrading Update
5th Mar 20263:39 pmRNSDirector/PDMR Shareholding
5th Mar 20267:00 amRNSAppointment of Independent Non-Executive Director
10th Feb 202612:32 pmRNS-RAppointment of Chief Commercial Officer
4th Feb 20267:00 amRNSAppointment of Nominated Adviser and Sole Broker
19th Jan 20261:33 pmRNSPDMR Dealing
23rd Dec 20257:00 amRNSPDMR Dealing
23rd Dec 20257:00 amRNSPDMR Dealing
1st Dec 20259:01 amRNSPDMR Dealing
28th Nov 20257:00 amRNSChange of Registered Office
27th Nov 20254:57 pmRNSCorrection: Exercise & Grant of Options and TVR
27th Nov 20257:30 amRNSExercise & Grant of Options, PDMR Dealings and TVR
27th Nov 20257:00 amRNSInterim Results
11th Nov 20257:00 amRNSTrading Update, Board Change and Notice of Results
30th Oct 20257:00 amRNSHolding(s) in Company
26th Sep 20257:00 amRNSResult of AGM
12th Sep 20257:00 amRNSDirector/PDMR Dealing
11th Sep 20257:00 amRNSDirector/PDMR Dealing
10th Sep 20257:00 amRNSDirector/PDMR Dealing
8th Sep 20257:00 amRNSDirector/PDMR Dealing
5th Sep 20257:00 amRNSDirector/PDMR Dealing
15th Aug 20254:20 pmRNSChange of Venue for the 2025 AGM
7th Aug 20257:00 amRNSAudited Annual Results and Notice of AGM
30th Jul 20257:00 amRNSNotice of Results
15th Jul 20257:00 amRNSBoard Changes and Trading Update
23rd Jun 20257:00 amRNSAppointment of CFO
17th Jun 20257:00 amRNSBoard Change and Trading Update
15th May 20257:00 amRNSGrant of Options and PDMR Dealings
9th May 20255:50 pmRNSDirector/PDMR Dealing
9th Apr 20257:00 amRNSExercise of Options, Director Dealings and TVR
1st Apr 20257:00 amRNSDirector/PDMR Dealing
31st Mar 20257:00 amRNSTrading Update and New University Contract Awards
28th Mar 20257:00 amRNSChange of Registered Office
11th Mar 20257:00 amRNSDirector/PDMR Dealings
6th Mar 20257:00 amRNSDirectorate Change
3rd Dec 20247:00 amRNSInterim Results
15th Nov 20247:00 amRNSTrading Update and Notice of Results
8th Oct 20244:04 pmRNSHolding(s) in Company
23rd Sep 20244:47 pmRNSResult of AGM
6th Sep 202412:30 pmRNSPosting of Annual Report and Notice of AGM
30th Jul 20247:00 amRNSAudited Annual Results and Notice of AGM
23rd Jul 20247:00 amRNSFull Year Trading Update
3rd Jun 20249:28 amRNSExercise of Options, Director Dealings and TVR
20th May 20247:00 amRNSGrant of Options and PDMR Dealings
1st May 20247:00 amRNSPre-Close Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.